Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term RADIATION-THERAPY. Found 27 abstracts

no pagination
Coit DG, Thompson JA, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daniels GA, Daud A, DiMaio D, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi S, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Martini MC, Olszanski AJ, Ross MI, Salama A, Swetter SM, Tanabe KK, Trisal V, Urist MM, McMillian NR, Ho M. Melanoma, Version 4.2014 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2014 May;12(5):621-9.   PMCID: No NIH funding
von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU, DeLaney TF, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM, Mayerson J, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Van Tine BA, Wayne JD, Bergman MA, Sundar H. Soft Tissue Sarcoma, Version 2.2014 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2014 Apr;12(4):473-83.   PMCID: No NIH funds
Efstathiou JA, Bae K, Shipley WU, Hanks GE, Pilepich MV, Sandler HM, Smith MR. Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31. Journal of Clinical Oncology. 2009 Jan;27(1):92-9.   PMCID: PMC2645096
Lango MN, Andrews GA, Ahmad S, Feigenberg S, Tuluc M, Gaughan J, Ridge JA. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathological residual carcinoma and prognosis. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2009 Mar;31(3):328-37.
Zubek VB, Konski A. Cost Effectiveness of Risk-Prediction Tools in Selecting Patients for Immediate Post-Prostatectomy Treatment. Molecular Diagnosis & Therapy. 2009 Jan;13(1):31-47.
Klein EE, Vicic M, Ma CM, Low DA, Drzymala RE. Validation of calculations for electrons modulated with conventional photon multileaf collimators. Physics in Medicine and Biology. 2008 Mar;53(5):1183-208.
Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EE, Cheung MR, Lee AK, Pollack A. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. International Journal of Radiation Oncology Biology Physics. 2008 Jan;70(1):67-74.
Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Kudrimoti MR, Fromm ML, Haddock MG, Schaefer P, Willett CG, Rich TA. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma - A randomized controlled trial. JAMA-Journal of the American Medical Association. 2008 Mar;299(9):1019-26.
Small W, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. International Journal of Radiation Oncology Biology Physics. 2008 Jun;71(2):428-34.
Suh WW, Blackstock AW, Herman J, Konski AA, Mohiuddin M, Poggi MM, Regine WF, Cosman BC, Saltz L, Johnstone PA. ACR appropriateness criteria on resectable rectal cancer. International Journal of Radiation Oncology Biology Physics. 2008 Apr;70(5):1427-30.
Wahl AO, Rademaker A, Kiel KD, Jones EL, Marks LB, Croog V, McCormick BM, Hirsch A, Karkar A, Motwani SB, Tereffe W, Yu TK, Sher D, Silverstein J, Kachnic LA, Kesslering C, Freedman GM, Small W. Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. International Journal of Radiation Oncology Biology Physics. 2008 Feb;70(2):477-84.
Che M, Desilvio M, Pollack A, Grignon DJ, Mohan Venkatesan V, Hanks GE, Sandler HM. Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: A study based on RTOG 9202. International Journal of Radiation Oncology Biology Physics. 2007 Nov;69(4):1117-23.
D'Ambrosio DJ, Hanlon AL, Al-Saleem T, Feigenberg SJ, Horwitz EM, Uzzo RG, Pollack A, Buyyounouski MK. The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer. International Journal of Radiation Oncology Biology Physics. 2007 Mar;67(4):1082-7.
Fan J, Luo W, Fourkal E, Lin T, Li J, Veltchev I, Ma CM. Shielding design for a laser-accelerated proton therapy system. Physics in Medicine and Biology. 2007 Jul;52(13):3913-30.
Jin L, Wang L, Li J, Luo W, Feigenberg SJ, Ma CM. Investigation of optimal beam margins for stereotactic radiotherapy of lung-cancer using Monte Carlo dose calculations. Physics in Medicine and Biology. 2007 Jun;52(12):3549-61.
Khor LY, Bae K, Pollack A, Hammond ME, Grignon DJ, Venkatesan VM, Rosenthal SA, Ritter MA, Sandler HM, Hanks GE, Shipley WU, Dicker AP. COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial. Lancet Oncology. 2007 Oct;8(10):912-20.
Lutz ST, Chow EL, Hartsell WF, Konski AA. A review of hypofractionated palliative radiotherapy. Cancer. 2007 Apr;109(8):1462-70.
Mell LK, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Antonadou D, Koukourakis M, Mundt AJ. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: A meta-analysis. International Journal of Radiation Oncology Biology Physics. 2007 May;68(1):111-8.
Morrow M, O'Sullivan MJ. The dilemma of DCIS. Breast. 2007 Dec;16:S59-S62.
Murphy MJ, Balter J, Balter S, BenComo JA, Das IJ, Jiang SB, Ma CM, Olivera GH, Rodebaugh RF, Ruchala KJ, Shirato H, Yin FF. The management of imaging dose during image-guided radiotherapy: Report of the AAPM Task Group 75. Medical Physics. 2007 Oct;34(10):4041-63.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term RADIATION-THERAPY

RADIATION-THERAPY radiotherapy CARCINOMA RADIOTHERAPY MEN CANCER CHEMOTHERAPY PROSTATE-CANCER CHEMORADIOTHERAPY MALIGNANCIES ADJUVANT THERAPY EXPERIENCE IRRADIATION RANDOMIZED-TRIAL PHASE-II RECURRENCE FEASIBILITY RADICAL PROSTATECTOMY SURVIVAL Oncology ERA hyperthermia MARROW SPECIMENS RADIOCHEMOTHERAPY CONCURRENT ECONOMIC-ANALYSIS dose SALVAGE MASTECTOMY local recurrence EXTENDED-FIELD ADJUVANT RADIOTHERAPY CARCINOMA-CELLS METASTATIC MELANOMA ASSOCIATION INOPERABLE STAGE-I ADVANCED PELVIC POSTOPERATIVE RADIOTHERAPY HORMONE AGONISTS FIELD MARGIN DOSE CALCULATION OPEN-LABEL RTOG GRADE RADICAL PREVENTION FAILURE SINGLE FRACTION RETROPERITONEAL SARCOMA prognosis IMPACT BONY LANDMARKS EORTC DISEASE HYPERTHERMIA SURGERY GERMLINE MUTATIONS RTOG 9202 protection ENERGY NEOADJUVANT PHASE-III CONE-BEAM-CT intensity-modulated radiotherapy Androgen deprivation and radiotherapy SELECTIVE CYCLOOXYGENASE-2 INHIBITOR PSA BONE-MARROW MULTIPLE FRACTIONS residual microscopic disease CYTOPROTECTOR AMIFOSTINE LOCAL RECURRENCE SYNDROME INTERFACES FAMILIAL ADENOMATOUS POLYPOSIS external beam symptom control AGONISTS HORMONE Gleason score NUCLEAR ACCUMULATION LINE P53 MEK INHIBITION TOMOTHERAPY COMPUTED-TOMOGRAPHY DATA POOLED ANALYSIS TAMOXIFEN ADJUVANT TREATMENT MUTATIONS METABOLIC COOPERATIVE-ONCOLOGY-GROUP Prognostic factor Gleason pattern radiation therapy repeat irradiation advanced prostate cancer toxicity DEFINITIVE RADIOTHERAPY MANAGEMENT prostate cancer TOTAL SCALP IRRADIATION PREDICTORS METASTATIC DISSEMINATION OROPHARYNGEAL CANCER response DECISION-ANALYSIS NSCLC CHEMORADIATION ELECTRON-BEAM RADIOTHERAPY CURATIVE RESECTION FLAT-PANEL IMAGER CELL LUNG-CANCER HUMAN BREAST-CANCER TUMOR PHASE-III TRIAL SYSTEM PROGNOSTIC-SIGNIFICANCE METASTASES BODY-COMPOSITION CUTANEOUS TOXICITY CONSERVATION THERAPY MEGAVOLTAGE PHOTON BEAMS patient preference BEAM Immunohistochemistry neck ACUTE HEMATOLOGIC TOXICITY LINEAR-ACCELERATOR LOCAL-CONTROL Locally OVER-EXPRESSION CONFORMAL RADIOTHERAPY BCL-2 breast cancer HYPERFRACTIONATED RADIATION REAL-TIME chemotherapy FLUOROURACIL PLASMA INTERACTIONS pelvic 78 GY WOMEN CARNEY-STRATAKIS GENERATION PREOPERATIVE RADIOTHERAPY amifostine p53 FOLLOW-UP GENE
Last updated on Wednesday, August 05, 2020